Completed PHASE2 INTERVENTIONAL NCT00998192

A Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the Lung

A Phase 2 Study of Intravenous Administration of REOLYSIN® (Reovirus Type 3 Dearing) in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the Lung

Sponsor: Oncolytics Biotech

Conditions Metastatic or Recurrent Squamous Cell Carcinoma of the Lung

Interventions Carboplatin Paclitaxel REOLYSIN

Updated 6 times since 2017 Last updated: Mar 29, 2016 Started: Oct 31, 2009 Primary completion: Sep 30, 2013 Completion: Aug 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00998192, this PHASE2 trial focuses on Metastatic or Recurrent Squamous Cell Carcinoma of the Lung and remains completed. Sponsored by Oncolytics Biotech, it has been updated 6 times since 2009, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Oct 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Oncolytics Biotech
University of Texas

Data source: Oncolytics Biotech

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Arlington, United States , Armonk, United States , Bedford, United States , Denton, United States , Fort Worth, United States , Garland, United States , Indianapolis, United States , Kingston, United States , Lewisville, United States , Los Angeles, United States and 6 more locations